Subclinical states of glucose intolerance and risk of death in the U.S
- PMID: 11289466
- DOI: 10.2337/diacare.24.3.447
Subclinical states of glucose intolerance and risk of death in the U.S
Abstract
Objective: Although clinically evident type 2 diabetes is a well-established cause of mortality, less is known about subclinical states of glucose intolerance.
Research design and methods: Data from the Second National Health and Nutrition Examination Survey Mortality Study, a prospective study of adults, were analyzed. This analysis focused on a nationally representative sample of 3,174 adults aged 30-75 years who underwent an oral glucose tolerance test at baseline (1976-1980) and who were followed up for death through 1992.
Results: Using 1985 World Health Organization criteria, adults were classified as having previously diagnosed diabetes (n = 248), undiagnosed diabetes (n = 183), impaired glucose tolerance (IGT) (n = 480), or normal glucose tolerance (n = 2,263). For these groups, cumulative all-cause mortality through age 70 was 41, 34, 27, and 20%, respectively (P < 0.001). Compared with those with normal glucose tolerance, the multivariate adjusted RR of all-cause mortality was greatest for adults with diagnosed diabetes (RR 2.11, 95% CI 1.56-2.84), followed by those with undiagnosed diabetes (1.77, 1.13-2.75) and those with IGT (1.42, 1.08-1.87; P < 0.001). A similar pattern of risk was observed for cardiovascular disease mortality.
Conclusions: In the U.S., there was a gradient of mortality associated with abnormal glucose tolerance ranging from a 40% greater risk in adults with IGT to a 110% greater risk in adults with clinically evident diabetes. These associations were independent of established cardiovascular disease risk factors.
Similar articles
-
Postchallenge hyperglycemia and mortality in a national sample of U.S. adults.Diabetes Care. 2001 Aug;24(8):1397-402. doi: 10.2337/diacare.24.8.1397. Diabetes Care. 2001. PMID: 11473076
-
Cardiovascular risk profile in individuals with borderline glycemia: the effect of the 1997 American Diabetes Association diagnostic criteria and the 1998 World Health Organization Provisional Report.Diabetes Care. 2000 Mar;23(3):278-82. doi: 10.2337/diacare.23.3.278. Diabetes Care. 2000. PMID: 10868851
-
Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994.Diabetes Care. 1998 Apr;21(4):518-24. doi: 10.2337/diacare.21.4.518. Diabetes Care. 1998. PMID: 9571335
-
Abnormal glucose tolerance and the risk of cancer death in the United States.Am J Epidemiol. 2003 Jun 15;157(12):1092-100. doi: 10.1093/aje/kwg100. Am J Epidemiol. 2003. PMID: 12796045
-
Impaired glucose tolerance--fact or fiction.Diabet Med. 1996;13(3 Suppl 2):S6-8. Diabet Med. 1996. PMID: 8689861 Review.
Cited by
-
Associations of impaired glucose tolerance and sleep disorders with mortality among the US general population.BMJ Open Diabetes Res Care. 2021 Aug;9(1):e002047. doi: 10.1136/bmjdrc-2020-002047. BMJ Open Diabetes Res Care. 2021. PMID: 34353879 Free PMC article.
-
Prediabetes and What It Means: The Epidemiological Evidence.Annu Rev Public Health. 2021 Apr 1;42:59-77. doi: 10.1146/annurev-publhealth-090419-102644. Epub 2021 Dec 23. Annu Rev Public Health. 2021. PMID: 33355476 Free PMC article. Review.
-
Risk factors in the illness-death model: Simulation study and the partial differential equation about incidence and prevalence.PLoS One. 2019 Dec 17;14(12):e0226554. doi: 10.1371/journal.pone.0226554. eCollection 2019. PLoS One. 2019. PMID: 31846478 Free PMC article.
-
Regression to Normal Glucose Regulation in American Indians and Alaska Natives of a Diabetes Prevention Program.Diabetes Care. 2019 Jul;42(7):1209-1216. doi: 10.2337/dc18-1964. Epub 2019 Jun 8. Diabetes Care. 2019. PMID: 31177184 Free PMC article. Clinical Trial.
-
Mortality risk in adults according to categories of impaired glucose metabolism after 18 years of follow-up in the North of Spain: The Asturias Study.PLoS One. 2019 Jan 31;14(1):e0211070. doi: 10.1371/journal.pone.0211070. eCollection 2019. PLoS One. 2019. PMID: 30703129 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grant support
LinkOut - more resources
Full Text Sources
